Grow & Processing:
A Vertically-Integrated Enterprise
canafarma will be the market’s only true vertically-integrated enterprise completely in control of its CBD products all the way from seed-to-counter.
Most of the CBD/Hemp Oil market is fragmented with small players each focused on one aspect of the CBD product chain; cultivation, processing, marketing & sales, and research & info publication.
From Seed to Counter
We are the only producer in the CBD market with our own:
- Exclusive Farm for Hemp Cultivation
- Processing Facility
- Research Staff
- Marketing Team
- Information and Marketplace Portal
OPERATING OUR OWN 55 ACRE FARM
PROVIDES IMMEDIATE AND LONG-TERM BENEFITS
Research and Testing
Cultivating and processing our own hemp will allow us to develop and accurately track the efficacy of countless formulations with different hemp strains and processing method combinations. Our relentless testing and research will permit us to create the best possible products for each segment of the CBD market.
Cultivation Operations and Processing
- Operates a 55 acre farm in Dutchess County, NY
- One of the first entities to be granted a hemp cultivation license in the state of New York.
- Many years of experience in choosing the perfect seeds and ensuring superior results
- Annual yield 130,000 to 200,000 pounds
- Enabling fully cultivation/sourcing of own hemp for our branded products
- Allows for profitable sales of the remainder of the crop as commodity biomass.
- Our own FDA approved GMP processing facility with pharmaceutical grade standards
- Able to fulfill a pressing demand among the ever-growing number of cultivators and producers, particularly on the east coast.
TOP U.S HEMP CULTIVATION STATES BY ACREAGE: 2018
canafarma operates a 55 acre farm in Dutchess County, NY that is ideal for growing top quality, organic, non-GMO, pesticide-free hemp. Annual yield from this farm is 130,000 to 200,000 pounds, enabling us to fully cultivate/source our own hemp for our branded products while profitably selling the remainder of the crop as commodity biomass.
As one of the first entities to be granted a hemp cultivation license by the State of New York, canafarma’s “farmers” have many years of experience in choosing the perfect seeds and ensuring superior results. Our farm will produce top quality, organic, non-GMO, pesticide-free hemp.
canafarma is currently awaiting approval of another hemp cultivation license in the state of Pennsylvania.
State of the art Processing
In addition to our cultivation license in New York, the Company expects to be granted its processing license in the state of Pennsylvania in the upcoming weeks.
Having our own FDA approved GMP processing facility with pharmaceutical grade standards will enable us to not only produce the highest quality CBD-based products, but also fulfill a pressing demand among the ever-growing number of cultivators and producers, particularly on the east coast.
Upon completion, our facility will be able to process 4,000 lbs of hemp per day.
canafarma will be private labelling carefully selected FDA registered products which will be distinctly differentiated from all the other products in the marketplace.
Unique Differentiators include:
- Full-Spectrum Phyto cannabinoid Hemp Oil
- Highest Absorption – Efficacy Rates.
Additional products designed by canafarma are expected to launch in Q3, 2019.
Unique Product Differentiators
Full-Spectrum Phyto-cannabinoid Hemp Oil
THC and CBD are only two of the over 100 cannabinoids found in hemp. These are also found in the human body and help regulate relaxation, appetite, sleep cycles, certain inflammation responses and cognitive functions including pain reception. Unlike the majority of products in the market that only offer CBD-isolate products, canafarma’s products will include the full spectrum of cannabinoids found in hemp.
Highest Absorption = Efficacy Rates
Ingested CBD-based products like tinctures, gummies, and capsules are absorbed through the body’s gastro-intestinal digestion system. This results in more than half of the cannabinoids being neutralized and wasted by the digestive process. canafarma’s unique products utilize a proprietary patented delivery system that bypasses the digestive system and allows for 97% absorption, requiring a substantially lower dosage for the same effect.
The CanaFarma Difference: Absorption and Bio Availability Rate
Low Absorption and Bioavailability rate are the major shortcomings of ingested CBD-based products. Over half of the cannabinoids in tincture oils, gummies, and capsules are neutralized and wasted by the gastro-intestinal digestive system. The percent of cannabinoids that reach the blood stream and are able to be used by the body is drastically lower than what is advertised on the product.
Absorption: The movement of a drug or nutrient into the bloodstream from the original intake system, such as the digestive system for pills and capsules.
Absorption affects Bioavailability
Bioavailability: A subcategory of absorption, it is the fraction of an administered dose of an unchanged drug/nutrient that reaches the systemic circulation and the target site of action.
canafarma’s patented delivery method allows 97% of the cannabinoids to reach the blood stream resulting in the best bioavailability rate available in the market.
Our cannabinoids are quickly absorbed through the mucous membranes of the mouth, which are very vascularized, allowing for rapid and more complete entry into the systemic circulation instead of having to go through the gastrointestinal tract. Significantly faster and more complete absorption and bioavailability rates reduce the level of cannabinoids required to achieve the desired physiological effect on the body.